Clay Scott of AstraZeneca to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6 (2008-04-02)
Dr. Clay Scott, Associate Director of the Lead Generation Department at AstraZeneca will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Clay will speak on experiences in lead generation focusing on cellular dielectric spectroscopy as a platform technology for GPCR screening.